Shalini Sharp - 17 May 2023 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Director
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Issuer symbol
NBIX
Transactions as of
17 May 2023
Net transactions value
$0
Form type
4
Filing time
19 May 2023, 17:22:50 UTC
Previous filing
24 Jan 2023
Next filing
13 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Non-Qualified Stock Option Award $0 +4,290 $0.000000 4,290 17 May 2023 Common Stock 4,290 $95.27 Direct F1
transaction NBIX Restricted Stock Unit Award $0 +2,100 $0.000000 2,100 17 May 2023 Common Stock 2,100 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests in 12 monthly installments beginning June 17, 2023.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
F3 The Restricted Stock Units will vest in full on May 17, 2024.